Applied Biokinetics LLC v. CVS Pharmacy, Inc.
6:21-cv-00557
Overview
Parties
Defendant
Mueller Sports Medicine, Inc. Operating Company
Represented By
1 Attorneys ListedRobinson & Cole LLP
Robinson & Cole LLP, Washington, DC 20024
CVS Pharmacy, Inc. Operating Company
Represented By
5 Attorneys ListedThompson Coburn LLP
2100 Ross Avenue, Ste 3200
Foley & Lardner LLP
555 South Flower Street, Suite 3300, Los Angeles, CA 90071
Foley & Lardner LLP
321 North Clark Street, Suite 3000, Chicago, IL 60654
Foley & Lardner LLP
555 South Flower Street, Suite 3300, Los Angeles, CA 90071
Foley & Lardner LLP
321 North Clark Street, Suite 3000, Chicago, IL 60654
Counter Defendant
Applied Biokinetics LLC Operating Company
Represented By
3 Attorneys ListedSorey & Hoover LLP
One Liberty Place, 100 N. 6th Street, Ste. 502
Katz PLLC
8350 N. Central Expressway, Suite 1900, Dallas, TX 75206
Sorey & Gilliland, LLP
133 E. Tyler Street, Longview, TX 75601
Court & Judges
Court
District Court, W.D. Texas (txwd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 16 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 8,414,511 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| π PCT International (WIPO) | WO 2005102233 A1 | PCT World Application | View Official Patent → |
| πΊπΈ United States | US 8,216,162 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,814,818 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,834,398 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,834,397 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,968,229 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 10,212,987 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2015000568 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 10,299,953 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 11,206,894 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 11,096,815 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 11,690,746 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 12,171,680 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 12,186,219 B2 | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 6 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8414511
System for treatment of plantar fasciitis
|
Filed: 2004-04-02
Issued: 2013-04-09
|
Active (2.4 yrs remaining)
+1836d PTA
Expires: 2029-04-12
|
|
|
US8968229
Disposable two-part orthotic foot support strap system and method
|
Filed: 2012-09-01
Issued: 2015-03-03
|
Expired (Term Ended)
Expires: 2025-05-23
|
|
|
US8216162
System for treatment of plantar fasciitis
|
Filed: 2005-06-23
Issued: 2012-07-10
|
Active (0.8 yrs remaining)
+796d PTA
Expires: 2027-08-28
|
|
|
US8814818
Disposable two-part orthotic foot support strap system and method
|
Filed: 2012-02-02
Issued: 2014-08-26
|
Expired (Term Ended)
Expires: 2025-02-12
|
|
|
US8834398
System for treatment of plantar fasciitis
|
Filed: 2012-05-21
Issued: 2014-09-16
|
Expired (Term Ended)
Expires: 2025-04-25
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
High PTA (+1836 days) / Cellect Scrutiny β Over 1836 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
37
Dispositive
17
Granted
6
Denied
0
Pending / Review
26
Motions by Category
Key Dispositive Motions & Rulings